Singapore, Singapore
The Singapore Immunology Network (SIgN) was launched by the Agency for Science, Technology and Research (A*STAR) in January of 2008. The mandate of SIgN is to advance human immunology research and participate in international efforts to combat major health problems. Researchers at SIgN investigate immunity during infections and inflammatory conditions, including cancer, using both mouse models and human tissues.